Progress, Potential, and Possibilities Show - Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us - Host - Ir…
33:542.8K views · 2d ago · 33:54
Nuclear power has a scale problem: conventional plants are enormous, expensive projects that can take years to build. Hadron Energy wants to take a different approach with a factory-manufactured, 10-megawatt light-water microreactor. But can a smaller reactor actually mean lower costs, simpler deployment and credible safety?
44:491.7K views · 4d ago · 44:49
Guest: Dr. Stella Vnook
The world doesn't have a shortage of promising medical discoveries. The real challenge is turning those discoveries into safe, effective, accessible treatments. What separates a breakthrough idea from a successful therapy? How could AI change the economics of drug development? And can regenerative medicine move healthcare beyond managing disease toward restoring damaged tissue? Today, we're tackling these questions with pharmaceutical executive and biotech entrepreneur Dr.
42:563.7K views · 4d ago · 42:56
What if we stopped thinking about antibodies as simply drugs that bind to one target - and started thinking about them as engineered molecular machines? Today we're talking about a bispecific antibody that targets both EGFR and LGR5, and asking whether that kind of antibody engineering could actually change the treatment landscape for head and neck cancer.
32:161.4K views · 6d ago · 32:16
What happens when you're 19 years old, physically fit, a collegiate wrestler, and you suddenly find yourself hospitalized for three days with influenza? Today's guest, Zachery Lang, experienced exactly that - and his story offers an important perspective on a disease many of us underestimate.
31:302.2K views · 1w ago · 31:30
Guest: Ericka Fusilier
Homelessness, addiction, mental health, aging and incarceration are often treated as separate problems. But for the people experiencing them, they're frequently connected. What would it take to build a system that sees the whole person - and could emerging technology help us get there?
44:411.7K views · 1w ago · 44:41
Guest: Robert Geho
What if the next breakthrough in diabetes treatment isn't necessarily a new drug molecule, but a better way to deliver the drugs we already have? One biotechnology company is developing a platform designed to target the liver with insulin - and exploring whether the same principle could eventually apply to GLP-1 and other metabolic therapies. Today, we're exploring the science, the clinical evidence, and what still needs to be proven.
52:073.4K views · 1w ago · 52:07
Cancer medicine is advancing rapidly. But are patients getting the tests and treatments they need to benefit from those advances? Chronic lymphocytic leukemia, or CLL, is one of the most common forms of adult leukemia. And while advances in targeted therapies have transformed the treatment landscape, a critical question remains: Are patients actually getting access to the right tests, the right treatments, and the right care at the right time?
59:232.6K views · 1w ago · 59:23
Guest: Deep Origin
A drug can look promising in the laboratory and still fail when it reaches human testing. One of the biggest challenges in drug development is predicting what a compound will actually do inside the human body - including whether it will cause dangerous side effects. Could AI help us make those predictions more accurately, before patients are ever exposed?
33:413.3K views · 1w ago · 33:41
Guest: Desmond Wheatley
We usually assume that before we can use electricity somewhere, we need to build the infrastructure to deliver it. But what if we could bring the energy infrastructure to the location instead? That's the idea behind Beam Global's approach to solar-powered EV charging, energy storage, and resilient power.
46:281.9K views · 1w ago · 46:28
Guest: Dr. Abigail Livny-Ezer
The brain is one of the most complex systems in biology, and understanding it requires more than a picture of its anatomy. We need to understand its connections, activity, and response to injury. Today we're going to ask a fascinating question: Can advanced neuroimaging and artificial intelligence give us a much better understanding of what happens to the brain after injury and disease - and ultimately help physicians make better decisions for individual patients?
37:176.2K views · 2w ago · 37:17
What happens when your ADHD medication wears off, but your day isn't over? Homework, family responsibilities, relationships, and everything else still demand your attention. So why are we still thinking about ADHD treatment in terms of the school day or the workday? Today, we're exploring whether a different approach to drug delivery could change that.
54:592.5K views · 2w ago · 54:59
Guest: Dr. Joseph Geraci
What if a promising drug fails a clinical trial not because the drug doesn't work, but because it works for a subset of patients whose response gets lost in the averages? What if AI could help us find those patients hidden inside the data? That's the challenge we're exploring today with mathematical scientist Dr. Joseph Geraci, Ph.D., co-founder and chief technology and science officer at NetraMark ( ).
Showing the 12 most recent episodes. Everything plays right here on Pod Atlas.
Have thoughts about Progress, Potential, and Possibilities? Share them with other listeners.
Discuss this podcast